aldosterone has been researched along with sirolimus in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Djurhuus, JC; Golbaekdal, K; Nielsen, CB; Pedersen, EB | 1 |
Johnson, JP; Palevsky, PM; Rokaw, MD; West, ME | 1 |
Boldyreff, B; Braun, S; Lösel, R; Wehling, M | 1 |
Mansley, MK; Wilson, SM | 1 |
Gu, Y; Huang, B; Jin, X; Li, F; Ning, G; Su, H; Sun, F; Wang, Q | 1 |
Ding, W; Gu, Y; Li, H; Wang, B; Zhang, M | 1 |
Betz, MJ; Beuschlein, F; Burkard, T; Cavelti-Weder, C; Donath, MY; Hall, MN; Hepprich, M; Kratschmar, DV; Meienberg, F; Odermatt, A; Reincke, M; Seelig, E; Swierczynska, MM; Trinh, B | 1 |
Ali, Y; Gomez-Sanchez, CE; Gomez-Sanchez, EP | 1 |
1 trial(s) available for aldosterone and sirolimus
Article | Year |
---|---|
Treatment of Primary Aldosteronism With mTORC1 Inhibitors.
Topics: Adult; Aldosterone; Angiotensin II; Animals; Blood Pressure; Everolimus; Female; Hemodynamics; Humans; Hyperaldosteronism; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, 129 Strain; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Pilot Projects; Proof of Concept Study; Renin; Sirolimus | 2019 |
7 other study(ies) available for aldosterone and sirolimus
Article | Year |
---|---|
Effects of rapamycin on renal hemodynamics, water and sodium excretion, and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide, and vasopressin in pigs.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Diuresis; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Heart Rate; Hemodynamics; Immunosuppressive Agents; Kidney; Lithium; Natriuresis; Polyenes; Renal Circulation; Sirolimus; Swine; Vasopressins | 1994 |
FK-506 and rapamycin but not cyclosporin inhibit aldosterone-stimulated sodium transport in A6 cells.
Topics: Aldosterone; Biological Transport; Cell Line; Cyclosporine; Electric Conductivity; Immunosuppressive Agents; Mineralocorticoid Receptor Antagonists; Nystatin; Polyenes; Sirolimus; Sodium; Tacrolimus; Time Factors | 1996 |
Aldosterone rapidly activates Src kinase in M-1 cells involving the mineralocorticoid receptor and HSP84.
Topics: Aldosterone; Animals; Blotting, Western; Cell Line; Dose-Response Relationship, Drug; Enzyme Activation; Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Kidney; Mice; Phosphorylation; Precipitin Tests; Receptors, Mineralocorticoid; Sirolimus; Spironolactone; src-Family Kinases; Time Factors; Tyrosine | 2004 |
Dysregulation of epithelial Na+ absorption induced by inhibition of the kinases TORC1 and TORC2.
Topics: Absorption; Aldosterone; Animals; Arginine Vasopressin; Cells, Cultured; Dexamethasone; Epithelial Cells; Immediate-Early Proteins; Insulin; Kidney Tubules, Collecting; Membrane Potentials; Mice; Naphthyridines; Phosphorylation; Protein Serine-Threonine Kinases; Sirolimus; Sodium; TOR Serine-Threonine Kinases | 2010 |
The PI3K/AKT/mTOR signaling pathway is overactivated in primary aldosteronism.
Topics: Adrenal Glands; Adult; Aldosterone; Cell Line; Cell Proliferation; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2013 |
Rapamycin attenuates aldosterone-induced tubulointerstitial inflammation and fibrosis.
Topics: Aldosterone; Animals; Antibiotics, Antineoplastic; Cell Line; Epithelial-Mesenchymal Transition; Extracellular Matrix; Fibrosis; Humans; Male; Nephritis, Interstitial; Phosphorylation; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Up-Regulation | 2015 |
Mammalian Target of Rapamycin Inhibition Decreases Angiotensin II-Induced Steroidogenesis in HAC15 Human Adrenocortical Carcinoma Cells.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Angiotensin II; Humans; Hydrocortisone; RNA, Guide, Kinetoplastida; Sirolimus; TOR Serine-Threonine Kinases | 2022 |